Article Details

Reviewing Innate Pharma (OTCMKTS:IPHYF) and Immunovant (NASDAQ:IMVT) - Defense World

Retrieved on: 2022-05-14 08:30:53

Tags for this article:

Click the tags to see associated articles and topics

Reviewing Innate Pharma (OTCMKTS:IPHYF) and Immunovant (NASDAQ:IMVT) - Defense World. View article details on HISWAI: https://www.defenseworld.net/2022/05/14/reviewing-innate-pharma-otcmktsiphyf-and-immunovant-nasdaqimvt.html

Excerpt

It develops IMVT-1401, a novel fully human monoclonal antibody that ... discovers, develops, and commercializes therapeutic antibodies for the ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up